Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2019

Open Access 01-12-2019 | Public Health | Commentary

Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project

Authors: Jesse Schnall, Arjun Rajkhowa, Kevin Ikuta, Puja Rao, Catrin E. Moore

Published in: BMC Medicine | Issue 1/2019

Login to get access

Excerpt

Reliable estimates of the current and future disease burden of antimicrobial resistance (AMR) are essential to combat the global drug-resistant infection crisis [1, 2]. Yet, despite considerable global efforts, our understanding of the burden of resistant infections remains disturbingly sparse [3]. More reliable, detailed and dynamic information is essential to successfully address an apparent rise in resistant infections, enabling policymakers and healthcare providers to implement national AMR action plans, and efficiently allocate resources. …
Literature
1.
2.
3.
Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD, et al. Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018;16(1):78.CrossRef
4.
GBD Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210.CrossRef
5.
Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.CrossRef
6.
7.
Cars O. Otto Cars: reacting to antimicrobial resistance. Interviewed by Gary Humphreys. Bull World Health Organ. 2019;97:384–5.
8.
9.
10.
Metadata
Title
Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project
Authors
Jesse Schnall
Arjun Rajkhowa
Kevin Ikuta
Puja Rao
Catrin E. Moore
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Public Health
Published in
BMC Medicine / Issue 1/2019
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-019-1412-8

Other articles of this Issue 1/2019

BMC Medicine 1/2019 Go to the issue

Research article

Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)

Research article

Thymic size is increased by infancy, but not pregnancy, nutritional supplementation in rural Gambian children: a randomized clinical trial

Research article

A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections

Research article

Building a learning community of Australian clinical genomics: a social network study of the Australian Genomic Health Alliance

Research article

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study

Research article

Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda